Oncology is a critical area of healthcare with challenges and opportunities for innovation, especially in drug development. Cancer is a leading cause of death in the US, with high costs and increasing prevalence. Pharma revenue from oncology drugs is significant and expected to rise. Challenges in drug development include trial design, patient identification, and engagement. Digital innovations like digital biomarkers, data utilization, and patient engagement platforms are helping address these challenges. By leveraging these innovations, the pharmaceutical industry can make significant progress in oncology drug development, ultimately improving outcomes for cancer patients.
Source link
The Opportunity for Digital Innovation in Oncology Drug Development
